Medicare Enrolled
Dr. Howard Tee, MD
Cardiovascular Disease · Vero Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tee? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tee
Dr. Howard Tee is a cardiovascular disease in Vero Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Tee performed 17,474 Medicare services across 6,908 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tee received a total of $54,973 from 54 pharmaceutical and/or device companies across 910 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tee is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in FL$ $54,973 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,474
Medicare services
Top 2% in FL for cardiovascular disease
6,908
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~920 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 5,256 | $0 | $30 |
| Office visit, established patient (30-39 min) | 4,817 | $95 | $168 |
| Electrocardiogram (EKG), 12-lead | 1,245 | $11 | $27 |
| Echocardiogram, transthoracic | 792 | $150 | $325 |
| Remote pacemaker/defibrillator monitoring, 90 days | 630 | $17 | $41 |
| Remote pacemaker monitoring, 90 days | 551 | $22 | $48 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 413 | $157 | $200 |
| Hospital follow-up visit, high complexity | 383 | $97 | $164 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 302 | $19 | $25 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 293 | $20 | $42 |
| New patient office visit (45-59 min) | 285 | $124 | $260 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 251 | $48 | $111 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 207 | $348 | $763 |
| Heart muscle strain imaging | 193 | $30 | $55 |
| Initial hospital admission, high complexity | 190 | $139 | $320 |
| Programming of dual lead pacemaker system | 172 | $28 | $91 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 161 | $19 | $41 |
| Chronic care management, first 20 min/month | 161 | $51 | $77 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 155 | $662 | $1,131 |
| Telephone medical discussion with physician, 5-10 minutes | 119 | $43 | $125 |
| Ultrasound of both sides of head and neck blood flow | 101 | $147 | $320 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 100 | $11 | $81 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 80 | $25 | $86 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 72 | $18 | $33 |
| Office visit, established patient (10-19 min) | 46 | $44 | $69 |
| Programming of dual lead implantable defibrillator system | 40 | $42 | $121 |
| Insertion of heart rhythm monitor under skin | 39 | $3,471 | $7,897 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 34 | $382 | $896 |
| Ultrasound of heart with probe in esophagus, with report | 34 | $85 | $385 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 31 | $168 | $269 |
| Hospital follow-up visit, moderate complexity | 30 | $65 | $128 |
| Cardiac catheterization | 29 | $248 | $1,613 |
| External shock to heart to regulate heart beat | 27 | $88 | $250 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 27 | $147 | $309 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $54 | $142 |
| Annual wellness visit, follow-up | 25 | $131 | $183 |
| Programming of multiple lead implantable defibrillator system | 24 | $44 | $132 |
| Chronic care management, additional 20 min/month | 23 | $38 | $60 |
| Programming of single lead pacemaker system | 22 | $25 | $77 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 18 | $14 | $150 |
| Ultrasound of leg arteries or artery grafts | 18 | $184 | $410 |
| Office visit, established patient, complex (40-54 min) | 16 | $118 | $227 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $313 | $1,929 |
| Complete ultrasound scan of abdomen | 12 | $84 | $192 |
| New patient office visit (30-44 min) | 11 | $84 | $171 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.7% high complexity
34.9% medium
51.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$54,973
Total received (2018-2024)
Avg $7,853/year across 7 years
Top 7% in FL for cardiovascular disease
54
Companies
910
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$29,488 (53.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,253 (42.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,232 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,748
2023$5,380
2022$3,397
2021$4,931
2020$1,731
2019$17,456
2018$18,330
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$27,682
Amgen Inc.
$3,402
Novo Nordisk Inc
$2,397
Boston Scientific Corporation
$2,288
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,273
Medtronic Vascular, Inc.
$2,183
CVRx, Inc.
$2,032
SANOFI-AVENTIS U.S. LLC
$1,101
AstraZeneca Pharmaceuticals LP
$1,022
Abbott Laboratories
$961
PFIZER INC.
$935
Kowa Pharmaceuticals America, Inc.
$897
Novartis Pharmaceuticals Corporation
$823
BIOTRONIK INC.
$707
Merck Sharp & Dohme LLC
$650
Impulse Dynamics (USA) Inc.
$480
Esperion Therapeutics, Inc.
$465
E.R. Squibb & Sons, L.L.C.
$427
Amarin Pharma Inc.
$360
Lundbeck LLC
$354
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$338
Actelion Pharmaceuticals US, Inc.
$329
Edwards Lifesciences Corporation
$300
Gilead Sciences, Inc.
$204
Regeneron Healthcare Solutions, Inc.
$204
ARBOR PHARMACEUTICALS, INC.
$189
Bayer HealthCare Pharmaceuticals Inc.
$183
Alnylam Pharmaceuticals Inc.
$183
Lilly USA, LLC
$149
Silk Road Medical, Inc.
$149
Akcea Therapeutics, Inc.
$147
Astellas Pharma US Inc
$146
Medicure Pharma Inc.
$139
Lexicon Pharmaceuticals, Inc.
$108
Merck Sharp & Dohme Corporation
$94
Resmed Corp
$76
Amryt Pharma Holdings Ltd
$65
Aegerion Pharmaceuticals, Inc.
$61
Medtronic, Inc.
$61
ABIOMED
$59
Coala Life Inc
$43
Currax Pharmaceuticals LLC
$39
Bayer Healthcare Pharmaceuticals Inc.
$34
Kestra Medical Technology Services, Inc.
$33
Allergan Inc.
$30
SCPHARMACEUTICALS INC.
$27
Kiniksa Pharmaceuticals, Ltd.
$23
Bardy Diagnostics, Inc.
$22
ATRICURE, INC.
$21
Arbor Pharmaceuticals, Inc.
$17
AltaThera Pharmaceuticals LLC
$17
Baxter Healthcare
$15
Sobi, Inc
$13
iRhythm Technologies, Inc.
$11
Top 3 companies account for 60.9% of total payments
Associated products mentioned in payments ›
AIRSENSE · AMPLATZER AMULET · AMVIA EDGE · AVEIR · AZURE XT DR MRI SURESCAN · Arcalyst · Assure WCD · Azure · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · CONTRAVE · CareLink · Carnation Ambulatory Monitor · Coala Heart Monitor · Cobalt · Confirm Rx · Connectivity and Remote care · Corlanor · ELIQUIS · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · Edora 8 DR-T · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FORTIFY ASSURA · FUROSCIX · GENERAL THERAPIES · Hillrom - Carnation Ambulatory Monitor · INVOKANA · Impella · Inpefa · JARDIANCE · JOT DX · JUXTAPID · Kerendia · LEQVIO · LEXISCAN · LIVALO · LifeVest · Livalo · MOUNJARO · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · REVEAL LINQ · RYBELSUS · Ranexa · Repatha · Reveal LINQ · Rivacor · SAPIEN 3 Ultra RESILIA · SQRX PULSE GENERATOR · Saxenda · Sotalol Hydrochloride · TEGSEDI · TRULICITY · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · Xience Sierra Coronary Stent System · ZIO Patch · ZYPITAMAG · Zypitamag
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for cardiovascular disease in FL.
Equivalent to $315 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
43
Per 100K population
26.2
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tee is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (speaking/promotional, top 7%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tee experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Based on Medicare claims data, Dr. Tee performed 5,256 injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tee receive payments from pharmaceutical companies?
Yes. Dr. Tee received a total of $54,973 from 54 companies across 910 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tee's costs compare to other cardiovascular diseases in Vero Beach?
Dr. Tee's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Vero Beach
Browse cardiovascular diseases in Vero Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology